Regeneration Technologies gets European approval to market Sterling implants

By Angela McDaniels

Seattle, June 1 - Regeneration Technologies Inc. has received its first CE Marks for several Sterling implants used in spinal, sports medicine and general orthopedic surgeries, according to a company news release. These xenograft implants can now be distributed throughout Europe.

The implants receiving the CE Mark are: Sterling Cancellous Chips, Sterling Cancellous Cubes, Sterling Suture Anchor, Sterling Interference Screw ST, Sterling Interference Screw HT, Sterling Impacted Cortical Wedge, Sterling Impacted Cortical Ring, Sterling SR, Sterling Machined Dowel and the Sterling HTO Wedge.

"We can now bring sterilized xenograft to surgeons internationally, supplementing the unmet demand for biological solutions in surgery," chairman, president and chief executive officer Brian K. Hutchison said in the release.

The company said its Sterling implants provide a natural alternative to autograft, allograft and synthetic resorbable materials and use Regeneration Technologies' patented BioCleanse Tissue Sterilization Process, which enables delivery of sterile xenograft implants with improved biocompatibility and preserved structural integrity.

Alachua, Fla.-based Regeneration processes allograft and xenograft tissue into shaped implants for use in orthopedic, cardiovascular and other surgeries.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.